Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas .

分享到

Link by DOI

作者单位: ⁹武汉大学口腔医学院口腔外科. ³山东省临沂市肿瘤医院省A级血管瘤特色专科. ⁶空军军医大学口腔医学院头颈肿瘤外科. ¹⁰上海曹安医院血管瘤科. ⁵复旦大学附属儿科医院外科. ²中国医科大学口腔医学院口腔颌面外科. ⁸山东大学齐鲁医院口腔颌面外科. ¹²山东省立第三医院两腺与血管瘤科. ¹上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科. ¹¹重庆医科大学附属儿童医院胃肠新生儿外科血管瘤专科. ⁷山东第一医科大学附属省立医院(山东省立医院)烧伤整形美容外科. ⁴上海交通大学医学院附属第九人民医院介入科.

摘要: Since 2008, propranolol has become the first-line treatment for infantile hemangiomas. Many researches have been reported on its treatment mechanism both at home and abroad, and several expert consensus or clinical practice guidelines have been formulated and published. In recent years, with the continuous accumulation of clinical experience, increasing number of basic research works, and deepening understanding of the pathogenesis of hemangioma and the mechanism of action of propranolol, it is ...更多; Since 2008, propranolol has become the first-line treatment for infantile hemangiomas. Many researches have been reported on its treatment mechanism both at home and abroad, and several expert consensus or clinical practice guidelines have been formulated and published. In recent years, with the continuous accumulation of clinical experience, increasing number of basic research works, and deepening understanding of the pathogenesis of hemangioma and the mechanism of action of propranolol, it is necessary to update the expert consensus to be more consistent with clinical practice, in order to guide medication and management, provide scientific norms for the clinical use of propranolol in the treatment of infantile hemangiomas. This updated version mainly simplified the process of clinical examination, medication, and monitoring, making it more convenient and operable.收起

列表公用js 卡片页统计

相同作者单位文献